Literature DB >> 27606816

Formulation, in vitro evaluation and kinetic analysis of chitosan-gelatin bilayer muco-adhesive buccal patches of insulin nanoparticles.

Zahra Mahdizadeh Barzoki1, Zahra Emam-Djomeh1,2, Elaheh Mortazavian3, Ali Akbar Moosavi-Movahedi4, M Rafiee Tehrani3.   

Abstract

The present study was performed to optimise the formulation of a muco-adhesive buccal patch for insulin nanoparticles (NPs) delivery. Insulin NPs were synthesised by an ionic gelation technique using N-di methyl ethyl chitosan cysteine (DMEC-Cys) as permeation enhancer biopolymer, tripolyphosphate (TPP) and insulin. Buccal patches were developed by solvent-casting technique using chitosan and gelatine as muco-adhesive polymers. Optimised patches were embedded with 3 mg of insulin-loaded NPs with a homogeneous distribution of NPs in the muco-adhesive matrix, which displayed adequate physico-mechanical properties. The drug release characteristics, release mechanism and kinetics were investigated. Data fitting to Peppas equation with a correlation coefficient indicated that the mechanism of drug release followed an anomalous transport that means drug release was afforded through drug diffusion along with polymer erosion. In vitro drug release, release kinetics, physical and mechanical studies for all patch formulations reflected the ideal characteristics of this buccal patch for the delivery of insulin NPs.

Entities:  

Keywords:  Buccal bilayer patch; central composite design; chitosan; drug release kinetic; gelatine; insulin NPs; patch formulation

Mesh:

Substances:

Year:  2016        PMID: 27606816     DOI: 10.1080/02652048.2016.1234513

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  1 in total

1.  Improved Ocular Bioavailability of Moxifloxacin HCl using PLGA Nanoparticles: Fabrication, Characterization, In-vitro and In-vivo Evaluation.

Authors:  Fahim Ullah Khan; Fazli Nasir; Zafar Iqbal; Steven Neau; Ismail Khan; Mohammad Hassan; Muhammad Iqbal; Aman Ullah; Sumaira Irum Khan; Mirina Sakhi
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.